U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  1. Compliance Actions and Activities

Learn about the types of warning letters on FDA's website.

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
  • To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.
 


Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt
US Specialty Formulations, LLC Division of Pharmaceutical Quality Operations I Compounding Pharmacy/Adulterated Drug Products
Fancystage Unipessoal, LDA Center for Drug Evaluation and Research | CDER CGMP/Finished Pharmaceuticals/Adulterated
Avaria Health & Beauty Corp. Center for Drug Evaluation and Research | CDER CGMP/Finished Pharmaceuticals/Adulterated
LCC Ltd. Center for Drug Evaluation and Research | CDER CGMP/Finished Pharmaceuticals/Adulterated
Suhan Aerosol Center for Drug Evaluation and Research | CDER CGMP/Finished Pharmaceuticals/Adulterated
STC India Private Limited Center for Food Safety and Applied Nutrition (CFSAN) CGMP/Food/Prepared, Packed or Held Under Insanitary Conditions/Adulterated
KM Pharmaceutical Co. Ltd. Center for Drug Evaluation and Research | CDER Refusal to Provide Access to and Copying of Records
Orchid Lifesciences Center for Drug Evaluation and Research | CDER CGMP/Finished Pharmaceuticals/Adulterated
Tan Alize Kozmetik Ve Temizlik Urunleri Center for Drug Evaluation and Research | CDER CGMP/Finished Pharmaceuticals/Adulterated
Sangleaf Pharm., Co. Ltd. Center for Drug Evaluation and Research | CDER Failure to Provide Information

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top